These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Identification of novel compounds inhibiting chikungunya virus-induced cell death by high throughput screening of a kinase inhibitor library. Cruz DJ; Bonotto RM; Gomes RG; da Silva CT; Taniguchi JB; No JH; Lombardot B; Schwartz O; Hansen MA; Freitas-Junior LH PLoS Negl Trop Dis; 2013; 7(10):e2471. PubMed ID: 24205414 [TBL] [Abstract][Full Text] [Related]
6. Proteomic profiling of chikungunya virus-infected human muscle cells: reveal the role of cytoskeleton network in CHIKV replication. Issac TH; Tan EL; Chu JJ J Proteomics; 2014 Aug; 108():445-64. PubMed ID: 24933005 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, antiviral evaluation, and In silico studies of acrylamides targeting nsP2 from Chikungunya virus. Souza BG; Choudhary S; Vilela GG; Passos GFS; Costa CACB; Freitas JD; Coelho GL; Brandão JA; Anderson L; Bassi ÊJ; Araújo-Júnior JX; Tomar S; Silva-Júnior EFD Eur J Med Chem; 2023 Oct; 258():115572. PubMed ID: 37364511 [TBL] [Abstract][Full Text] [Related]
8. Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates. Akhrymuk I; Lukash T; Frolov I; Frolova EI J Virol; 2019 Feb; 93(4):. PubMed ID: 30487275 [TBL] [Abstract][Full Text] [Related]
9. Identification of tyrphostin AG879 and A9 inhibiting replication of chikungunya virus by screening of a kinase inhibitor library. He Y; Pan Z; Liu Y; Jiang L; Peng H; Zhao P; Qi Z; Liu Y; Tang H Virology; 2023 Nov; 588():109900. PubMed ID: 37832343 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression. Kaur P; Thiruchelvan M; Lee RC; Chen H; Chen KC; Ng ML; Chu JJ Antimicrob Agents Chemother; 2013 Jan; 57(1):155-67. PubMed ID: 23275491 [TBL] [Abstract][Full Text] [Related]
11. Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents. Jadav SS; Sinha BN; Hilgenfeld R; Jayaprakash V Curr Comput Aided Drug Des; 2017 Nov; 13(4):346-361. PubMed ID: 28294048 [TBL] [Abstract][Full Text] [Related]
12. Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses. Varghese FS; Kaukinen P; Gläsker S; Bespalov M; Hanski L; Wennerberg K; Kümmerer BM; Ahola T Antiviral Res; 2016 Feb; 126():117-24. PubMed ID: 26752081 [TBL] [Abstract][Full Text] [Related]
13. Discovery and development of labdane-oxindole hybrids as small-molecule inhibitors against chikungunya virus infection. Tran QTN; Lee RCH; Liu HJ; Ran D; Low VZL; To DQ; Chu JJH; Chai CLL Eur J Med Chem; 2022 Feb; 230():114110. PubMed ID: 35085859 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic strategies to control chikungunya virus infection. Hucke FIL; Bestehorn-Willmann M; Bugert JJ Virus Genes; 2021 Apr; 57(2):133-150. PubMed ID: 33590406 [TBL] [Abstract][Full Text] [Related]
16. Host ESCRT factors are recruited during chikungunya virus infection and are required for the intracellular viral replication cycle. Torii S; Orba Y; Sasaki M; Tabata K; Wada Y; Carr M; Hobson-Peters J; Hall RA; Takada A; Fukuhara T; Matsuura Y; Hall WW; Sawa H J Biol Chem; 2020 Jun; 295(23):7941-7957. PubMed ID: 32341071 [TBL] [Abstract][Full Text] [Related]
17. Antiviral activity of nobiletin against chikungunya virus in vitro. Lin SC; Chen MC; Li S; Lin CC; Wang TT Antivir Ther; 2017; 22(8):689-697. PubMed ID: 28406093 [TBL] [Abstract][Full Text] [Related]
18. Anti-Chikungunya Virus Monoclonal Antibody That Inhibits Viral Fusion and Release. Tumkosit U; Siripanyaphinyo U; Takeda N; Tsuji M; Maeda Y; Ruchusatsawat K; Shioda T; Mizushima H; Chetanachan P; Wongjaroen P; Matsuura Y; Tatsumi M; Tanaka A J Virol; 2020 Sep; 94(19):. PubMed ID: 32699087 [TBL] [Abstract][Full Text] [Related]